drugset / Trial / NCT00028067

A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor

NCT00028067

Phase 3 Terminated 500 enrolled Bristol-Myers Squibb
Treatment

Summary

The purpose of this study is to compare the atazanavir and nelfinavir (NFV) treatments in their ability to reduce viral load.

Timeline

Start
2001-08
Primary completion
2002-04
Completion
2002-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Atazanavir Other / unclassified
Subject Nelfinavir Other / unclassified